Here are 13 key notes on orthopedic and spine device companies over the past week.
AlloSource received a patent for its regenerative medicine product AlloStem Cellular Bone Allograft.
Shares of Alphatec Holdings, parent company of Alphatec Spine, have dipped 4.39 percent over the past week.
Checkpoint Surgical closed its first round of financing and raised $7.5 million.
ChoiceSpine received FDA 510(k) clearance for the TOMCAT stand-alone cervical device.
DeGen Medical received FDA clearance for the Latitude-C Cervical Interbody Spacer System.
LDR shares increased by 7.04 percent during the past week.
Nextremity Solutions received FDA clearance for the Axi+Line Proximal Bunion Correction System.
Pinnacle Spine Group received a patent titled "Intervertebral Implants and Related Tools," the third covering the company's InFill fusion technology.
SeaSpine signed a three-year credit facility with Wells Fargo Capital Finance.
Stryker Director Ronda E. Stryker sold 18,000 shares in a recent transaction.
An Ohio judge ruled accusations against Stryker's CerviCore can't be filed under a seal.
Stryker set aside around $18 billion for the acquisition of Smith & Nephew, a person with knowledge of the situation has said.
The first surgical procedure of Xtant Medical's Aranax Cervical Plating System has been successfully completed.